Response to "Studies on hemostasis in COVID-19 deserve careful reporting of the laboratory methods, their significance and their limitation": don't throw the baby out with the bathwater.
Response to "Studies on hemostasis in COVID-19 deserve careful reporting of the laboratory methods, their significance and their limitation": don't throw the baby out with the bathwater.
J Thromb Haemost. 2020 Aug 28;:
Authors: Nougier C, Benoit R, Dargaud Y
Abstract
We appreciate the opportunity to respond to the letter from Dr Hardy and colleagues (1). The authors stress on the large variability observed between different anti-Xa kits available on the market, they contest our results of thrombin generation assay (TGA) in patients with COVID-19 receiving standard- or high-dose prophylaxis and question the relevance of thromboelastography as a global haemostasis assay. We would like to bring responses to the methodological concerns raised by the authors.
PMID: 32860301 [PubMed - as supplied by publisher]
Source: Thrombosis and Haemostasis - Category: Hematology Authors: Nougier C, Benoit R, Dargaud Y Tags: J Thromb Haemost Source Type: research